Many have bought this stock when it was in the 20s. Its had a remarkable falls since then, deservingly or not. There is hope that the value becomes realized if the stock gets more coverage, but this stock has done nothing to impress anybody in the last six months. It may have long term potential, but clearly nothing to get excited about right now.
[It may have long term potential, but clearly nothing to get excited about right now.]
I would agree; the market has reached the same conclusion, unfortunately. Weak stock market climate generally. Revenue not growing fast enough to justify a high valuation. Continued losses. Share dilutions. Now a new acquisition to integrate. Some clinical uncertainty over the use of stents. Ugly chart. Really almost a whiff of desperation rhetoric at times -- the repeated chatter about investing in the sales force etc, trying to prop up the stock price. So overall not an attractive picture.
But anytime a stock makes a 52 wk low you will get talk about an entry point. But there are more attractive places to put money now. Wait for a solid uptrend.